Results 21 to 30 of about 228 (101)
Influenza and Other Respiratory Viruses, Volume 16, Issue 2, Page 351-365, March 2022., 2022 Abstract Reliable country‐specific data on influenza burden play a crucial role in informing prevention and control measures. Our purpose was to provide a comprehensive summary of the available evidence on the burden of seasonal influenza in Italy. We performed a systematic literature review of articles published until July 31, 2020.
Irene Giacchetta +4 more
wiley +1 more source
Viral community acquired pneumonia at the emergency department: Report from the pre COVID‐19 age
Journal of Medical Virology, Volume 93, Issue 7, Page 4399-4404, July 2021., 2021 Abstract The role of viruses in community acquired pneumonia (CAP) has been largely underestimated in the pre‐coronavirus disease 2019 age. However, during flu seasonal early identification of viral infection in CAP is crucial to guide treatment and in‐hospital management. Though recommended, the routine use of nasopharyngeal swab (NPS) to detect viral
Ornella Spagnolello +16 more
wiley +1 more source
Influenza and Other Respiratory Viruses, Volume 15, Issue 1, Page 81-90, January 2021., 2021 Abstract Background This study aims to quantify the excess of sickness absenteeism among healthcare workers (HCWs), to estimate the impact of a severe versus moderate influenza season and to determine whether the vaccination rates are associated with reduced sickness absence.
Maria Michela Gianino +5 more
wiley +1 more source
Influenza vaccine effectiveness in children: a retrospective study on eight post-pandemic seasons with trivalent inactivated vaccine. [PDF]
Acta Biomed, 2020 Background and aim of the work: The global burden of disease attributable to seasonal influenza virus in children is difficult to quantify. Children with chronic medical conditions and healthy children may experience severe or fatal complications. Aim of
Colucci ME +10 more
europepmc +2 more sources
ARVI: rational pharmacotherapy from the standpoint of clinical pharmacology
Медицинский совет, 2016 More than 30 million cases of influenza and acute respiratory viral infections are registered in Russia every year. Therefore, the problem of adequate pharmacotherapy is turning into a real challenge.
N. B. Lazareva +2 more
doaj +1 more source
Pharmacological and non-pharmacological treatments for ARVI
Медицинский совет, 2015 ARVI is one of the most common diseases worldwide. Search for adequate treatment remains an urgent public healthcare problem globally. The main task is still an effective and safe relief of ARVI symptoms, for the purpose of which both pharmacological and
I. L. Lazarevich
doaj +1 more source
Медицинский совет, 2014 The article considers current issues of the pathogenesis of acute respiratory viral infections (ARVI); there is current data on the advantages and disadvantages of the main groups of drugs used in the pharmacotherapy of ARVI.
O. A. Mubarakshina
doaj +1 more source
Clinical pattern, diagnosis and treatment of flu and ARVI
Медицинский совет, 2015 Flu and ARVI are among the most dangerous infectious diseases recorded in Russia, both in terms of the financial burden and the damage they cause to the health of the population.
K. A. Aitov
doaj +1 more source
ARVI: rational pharmacotherapy
Медицинский совет, 2014 ARVI is the most common group of mass diseases and number one among infectious diseases. Adequate protection against influenza and ARVI can be achieved with the help of modern drugs that create a barrier on the way of the virus and increase the body's ...
N. I. Lapidus
doaj +1 more source
A COMPREHENSIVE APPROACH TO THE TREATMENT OF INFLUENZA AND ARVI
Медицинский совет, 2017 The past XX century and early XXI century are marked by a widespread increase in viral infections, regardless of the level of socio-economic development of the country.
L. V. Luss
doaj +1 more source